Scilex Holding Company Proceeds from Issuance of Other Long-term Debt
Scilex Holding Company (SCLX) reported Proceeds from Issuance of Other Long-term Debt of $1.53 million for the 9-month period ending 2022-09-30, per its 10-Q filed 2022-11-04.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfOtherLongTermDebt · last filed 2022-11-04
- Scilex Holding Company proceeds from issuance of other long-term debt for the quarter ending 2022-09-30 was $0.00.
- Scilex Holding Company proceeds from issuance of other long-term debt for the quarter ending 2022-06-30 was $0.00.
- Scilex Holding Company proceeds from issuance of other long-term debt for the quarter ending 2022-03-31 was $1.53M.
- Scilex Holding Company proceeds from issuance of other long-term debt for fiscal 2021 was $500.00K.
| Period end | Proceeds from Issuance of Other Long-term Debt 3 month | Proceeds from Issuance of Other Long-term Debt 6 month | Proceeds from Issuance of Other Long-term Debt 9 month | Proceeds from Issuance of Other Long-term Debt 12 month |
|---|---|---|---|---|
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04 | $0.00 derived: sum of 2 quarters · filed 2022-11-04 | $1.53M 10-Q · filed 2022-11-04 | |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | $1.53M 10-Q · filed 2022-08-12 | ||
| 2022-03-31 | $1.53M 10-Q · filed 2022-05-16 | |||
| 2021-12-31 | $500.00K 10-K · filed 2022-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |
| Quince Therapeutics, Inc. (QNCX) | United States | $0.031B | |
| CEL SCI CORP (CVM) | United States | $0.030B | -0.81 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |